Detalhe da pesquisa
1.
Abnormalities in the KRAS Gene and Treatment Options for NSCLC Patients with the G12C Mutation in This Gene-A Literature Review and Single-Center Experience.
Biomedicines
; 12(2)2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397927
2.
Breaking the 'Undruggable' Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations-A Comprehensive Review and Description of Single Site Experience.
Cancers (Basel)
; 15(14)2023 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509393
3.
In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation.
Sci Rep
; 12(1): 8370, 2022 05 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589776
4.
Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation-Case Report and a Literature Review.
Curr Oncol
; 29(5): 3531-3539, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35621675
5.
The efficacy of T790M mutation testing in liquid biopsy-Real clinic data.
PLoS One
; 17(5): e0267846, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35522668
6.
Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.
Oncol Lett
; 13(6): 4433-4444, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28599445
7.
Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma.
Arch Med Sci
; 16(6): 1496-1500, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224359